600.02 1-Year Outcomes of Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Patients at Intermediate Surgical Risk: A Propensity-Match Analysis from the SURTAVI Trial

Abstract

The SURTAVI trial demonstrated the noninferiority of transcatheter aortic valve replacement (TAVR) using a self-expanding valve to surgical aortic valve replacement (SAVR) in patients with severe, symptomatic aortic stenosis at intermediate risk for surgery. The majority of TAVR patients in SURTAVI